Oxeon

Oxeon's investment pipeline flows directly from its executive search practice. The firm's constant interaction with CEOs, boards, and private equity sponsors across the healthcare sector surfaces market gaps and unmet clinical needs. When the search team repeatedly encounters the same structural problem — such as fragmented addiction treatment delivery — Oxeon may opt to build a company to address it rather than simply filling a role at an existing organization. This reactive origination model is distinct from a traditional venture firm's inbound-deck or warm-introduction funnel.

Oxeon is both, operating a dual-structure platform. The retained executive search business places senior leaders into healthcare companies across growth equity, venture, and public-company environments. The venture arm incubates and invests in early-stage healthcare companies, often using concepts identified through the search practice. The firm does not fit neatly into either category because the two functions are financially and operationally intertwined — search fees fund venture activity, and the venture portfolio reinforces the search practice's sector expertise.

Oxeon conceived the business concept for Eleanor Health, a value-based addiction treatment provider, and recruited its co-founder and chief medical officer to build the company. The firm describes this as a formative example of its venture-creation model: identifying a systemic healthcare problem, designing a company to address it, and placing leadership before seeking external growth capital. Eleanor Health operates as an independent entity with Oxeon as a founding stakeholder.

Oxeon does not publicly disclose a formal fund structure or limited partner base. The firm states that its venture activities are funded through the profitability of its executive search practice, making it effectively self-capitalized for early-stage incubation. Because it does not report a traditional AUM or fund close, its capital base remains undisclosed to outside observers.

Oxeon is 100% healthcare-focused, with particular depth in value-based care, behavioral health, digital health, care delivery innovation, and healthcare IT. The firm maintains a dedicated Clinician Leadership practice to place chief medical officers and clinical executives, reflecting a concentration on provider-adjacent and care-model businesses rather than pure life sciences or medical device plays.

Oxeon operates from three US offices: New York (headquarters), Nashville, and Seattle. Each office has geographic and subsector specialization. The Nashville office, led by Partner Tom Keefe, concentrates on growth and private equity-backed healthcare IT and services. The Seattle office, under Director Dylan, covers biopharma, medical technology, and healthcare services. The distributed structure allows the firm to maintain relationships across regional healthcare clusters while executing national searches.

Sonia Millsom serves as CEO, leading the firm's daily operations and strategic direction. Founder Trevor Price remains Chairman, focusing on entrepreneurship, investment, and connecting people and ideas across the healthcare ecosystem. The executive team is rounded out by Partners Patrick Sullivan (Executive Search), Tom Keefe (Nashville), and Dr. Reena Pande (Clinician Leadership), creating a partnership structure that separates search delivery from venture and incubation activities.